Literature DB >> 15588381

Thyroid carcinomas involving follicular and parafollicular C cells: seventeen cases with characterization of RET oncogenic activation.

M-C Vantyghem1, P Pigny, E Leteurtre, L Leclerc, C Bauters, C Douillard, M D'Herbomez, B Carnaille, C Proye, J-L Wemeau, M Lecomte-Houcke.   

Abstract

Recent studies have focused on the occurrence of concomitant medullary-papillary thyroid carcinomas (MTC-PTC). The aims of this report were to compare the frequency of occult PTC in a population with MTC versus a control population that had undergone thyroidectomies and to check whether differences could be related to particular phenotype or genotype. To achieve these goals, we determined the frequency of occult PTC among patients operated for MTC (n = 82) or undergoing total thyroidectomy mainly for goiter and/or nodules (n = 7313) between 1994-2001. We then examined the clinical, histologic, and genetic characteristics (using a bio-chemical family inquiry and screening for RET germline mutations) of patients with associated PTC-MTC. Results show a significantly higher frequency of occult PTC in MTC (14.7%) than in total thyroidectomy (6.8%; p < 0.01). Seventeen cases of MTC or bilateral C-cell hyperplasia (CCH) and separate occult PTC were identified from 16 different families. Although common RET mutations providing evidence of familial forms of MTC were identified in only 3 of 16 families, clinical and histologic features usually seen in inherited forms of MTC such as young age of occurrence, bilateral CCH or associated case in family were found in 11 of the remaining 14 patients. In conclusion, results suggest that the association of MTC-PTC is not only a coincidence. Surprisingly, 11 of 17 MTC-PTC patients exhibited clinical, histologic, and/or family features usually encountered in familial forms despite the fact that no RET defect were present. This suggests the possible involvement of another gene or uncommon abnormality of RET gene.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15588381     DOI: 10.1089/thy.2004.14.842

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  8 in total

1.  Absence of RET gene point mutations in sporadic thyroid C-cell hyperplasia.

Authors:  Enrico Saggiorato; Ida Rapa; Francesca Garino; Gianni Bussolati; Fabio Orlandi; Mauro Papotti; Marco Volante
Journal:  J Mol Diagn       Date:  2007-04       Impact factor: 5.568

2.  The Growth Kinetics of Collision Nodal Metastasis from Medullary and Papillary Thyroid Carcinomas: A Case Report.

Authors:  Hao Li; Nir Livneh; Snjezana Dogan; Ashok R Shaha
Journal:  Eur Thyroid J       Date:  2020-11-10

Review 3.  [Thyroid C cells and their pathology: Part 2: Medullary thyroid carcinoma].

Authors:  S Synoracki; S T Schmid; S Ting; K W Schmid
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

Review 4.  On the Origin of Cells and Derivation of Thyroid Cancer: C Cell Story Revisited.

Authors:  Mikael Nilsson; Dillwyn Williams
Journal:  Eur Thyroid J       Date:  2016-06-24

5.  Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumor with lymph node metastasis: A case report.

Authors:  Mehr Sadat Alavi; Negar Azarpira
Journal:  J Med Case Rep       Date:  2011-12-20

6.  Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma in the Same Patient as a Collision Tumour.

Authors:  Oguz Dikbas; Aslihan Alpaslan Duman; Gulname Findik Guvendi
Journal:  Case Rep Endocrinol       Date:  2019-03-12

Review 7.  Collision tumors of the thyroid. A special clinical and pathological entity.

Authors:  Andreea Bojoga; Laura Stănescu; Corin Badiu
Journal:  Arch Clin Cases       Date:  2021-12-29

8.  Twenty years of experience with the preoperative diagnosis of medullary cancer in a moderately iodine-deficient region.

Authors:  Tamas Solymosi; Gyula Lukacs Toth; Dezso Nagy; Istvan Gal
Journal:  Int J Endocrinol       Date:  2013-03-06       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.